Search Constraints
« Previous |
11 - 20 of 21
|
Next »
Search Results
Select an image to start the slideshow
Ultrastructural Plasticity of Pallidothalamic GABAergic Terminals in Parkinson’s Disease: A 3D Electron Microscopy Study in the Parvocellular Ventral Anterior and Centromedian Thalamic Nuclei in MPTP-Treated Parkinsonian Monkeys
1 of 10
A role for the synaptic vesicle glycoprotein 2C (SV2C) in
dopamine homeostasis and Parkinson's disease
2 of 10
Synaptic Vesicle Glycoprotein 2C (SV2C) in Parkinson's Disease-Related Striatal Vesicular Dysfunction
3 of 10
Effects of Dopamine D1-Like Receptor Activation in the Internal Pallidal Segment and the Substantia Nigra Pars Reticulata of Normal and Parkinsonian Primates
4 of 10
Reduced vesicular storage of catecholamines in the pathogenesis of
Parkinson's Disease
5 of 10
Glutamatergic Inputs to the Monkey Subthalamic Nucleus: A
Comparison of Relative Abundance, Synaptology and Functional
Connectivity in Normal versus Parkinsonian Conditions.
6 of 10
Impaired vesicular storage of norepinephrine and serotonin in Parkinson's disease-related pathogenesis
7 of 10
Pesticides and Parkinson's disease: Attributable Risk of
Occupational Exposure and Neurochemical Analysis of Sub-Chronic
Environmental Exposure
8 of 10
RING FINGER PROTEIN 11 (RNF11) MEDIATES NF-κB SIGNALING AND
DOPAMINERGIC NEURODEGENERATION
9 of 10
Optimized Delivery of C3 Transferase by Lentiviral Vectors forCNS Injury Therapy
10 of 10